Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Neoplasms, Squamous Cell 1Neoplasms 1Lung Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 14pembrolizumab 13Paclitaxel 13Oxaliplatin 13Leucovorin 10Carboplatin 9Radiotherapy 8Capecitabine 8Trastuzumab 7Nivolumab 7Drug Therapy 7Cisplatin 7Radiation 6Esophagectomy 6Taxes 5Specimen Handling 5Irinotecan 4trastuzumab deruxtecan 3tislelizumab 3patritumab deruxtecan 3Surgical Procedures, Operative 3Radiotherapy, Intensity-Modulated 3Immunotherapy 3Blood Specimen Collection 3zanidatamab 2ulixertinib 2trastuzumab biosimilar HLX02 2relatlimab 2durvalumab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Biological Products × 90 days × Clear all
NCT04908111 2026-04-06

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Cancer Research UK

Phase 1/2 Suspended
15 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡